Listed

Arcutis Biotherapeutics, Inc.

ARQTNasdaqCIK 1787306HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$129.9m, Q2 FY2026
Operating income$16.4m, Q2 FY2026
Net income$15.0m, Q2 FY2026
Arcutis Biotherapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m38.1Revenue, Q3 FY2023, three months to 2023-09-30$38.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure13.5Revenue, Q4 FY2023, three months to 2023-12-31$13.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure49.6Revenue, Q1 FY2024, three months to 2024-03-31$49.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure30.9Revenue, Q2 FY2024, three months to 2024-06-30$30.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure44.8Revenue, Q3 FY2024, three months to 2024-09-30$44.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure71.4Revenue, Q4 FY2024, three months to 2024-12-31$71.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure65.8Revenue, Q1 FY2025, three months to 2025-03-31$65.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure81.5Revenue, Q2 FY2025, three months to 2025-06-30$81.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure99.2Revenue, Q3 FY2025, three months to 2025-09-30$99.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure130Revenue, Q4 FY2025, three months to 2025-12-31$129.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure105Revenue, Q1 FY2026, three months to 2026-03-31$105.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure130Revenue, Q2 FY2026, three months to 2026-06-30$129.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Cost of revenue$m1.2Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure2.2Cost of revenue, Q4 FY2023, three months to 2023-12-31$2.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure3.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$3.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure3.5Cost of revenue, Q2 FY2024, three months to 2024-06-30$3.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure5.5Cost of revenue, Q3 FY2024, three months to 2024-09-30$5.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure6.9Cost of revenue, Q4 FY2024, three months to 2024-12-31$6.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure8.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$8.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure7.5Cost of revenue, Q2 FY2025, three months to 2025-06-30$7.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure8.7Cost of revenue, Q3 FY2025, three months to 2025-09-30$8.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure11.7Cost of revenue, Q4 FY2025, three months to 2025-12-31$11.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure9.8Cost of revenue, Q1 FY2026, three months to 2026-03-31$9.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure10.9Cost of revenue, Q2 FY2026, three months to 2026-06-30$10.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Research and development$m26.2Research and development, Q3 FY2023, three months to 2023-09-30$26.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure23.8Research and development, Q4 FY2023, three months to 2023-12-31$23.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure23.1Research and development, Q1 FY2024, three months to 2024-03-31$23.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure19.3Research and development, Q2 FY2024, three months to 2024-06-30$19.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure19.5Research and development, Q3 FY2024, three months to 2024-09-30$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure14.5Research and development, Q4 FY2024, three months to 2024-12-31$14.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure17.5Research and development, Q1 FY2025, three months to 2025-03-31$17.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure19.5Research and development, Q2 FY2025, three months to 2025-06-30$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure19.6Research and development, Q3 FY2025, three months to 2025-09-30$19.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure20.5Research and development, Q4 FY2025, three months to 2025-12-31$20.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure30.6Research and development, Q1 FY2026, three months to 2026-03-31$30.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure20.4Research and development, Q2 FY2026, three months to 2026-06-30$20.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Selling, general and administrative$m47.6Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$47.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure48.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$48.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure54.8Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$54.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure58.2Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$58.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure58.8Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$58.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure57.6Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$57.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure64.0Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$64.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure69.2Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$69.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure62.4Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$62.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure79.0Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$79.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure74.1Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$74.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure82.1Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$82.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Operating income$m(36.9)Operating income, Q3 FY2023, three months to 2023-09-30−$36.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure(61.2)Operating income, Q4 FY2023, three months to 2023-12-31−$61.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(31.6)Operating income, Q1 FY2024, three months to 2024-03-31−$31.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure(50.1)Operating income, Q2 FY2024, three months to 2024-06-30−$50.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure(39.1)Operating income, Q3 FY2024, three months to 2024-09-30−$39.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure(7.6)Operating income, Q4 FY2024, three months to 2024-12-31−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(24.5)Operating income, Q1 FY2025, three months to 2025-03-31−$24.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure(14.6)Operating income, Q2 FY2025, three months to 2025-06-30−$14.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure8.5Operating income, Q3 FY2025, three months to 2025-09-30$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure18.4Operating income, Q4 FY2025, three months to 2025-12-31$18.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Operating income, Q1 FY2026, three months to 2026-03-31−$9.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure16.4Operating income, Q2 FY2026, three months to 2026-06-30$16.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Interest expense$m7.6Interest expense, Q3 FY2023, three months to 2023-09-30$7.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-03, accession 0001787306-23-000124.Report this figure7.8Interest expense, Q4 FY2023, three months to 2023-12-31$7.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-27, accession 0001787306-24-000031. Derived: 12-month figure less the 9-month figure.Report this figure7.5Interest expense, Q1 FY2024, three months to 2024-03-31$7.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-14, accession 0001787306-24-000079.Report this figure7.5Interest expense, Q2 FY2024, three months to 2024-06-30$7.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure6.7Interest expense, Q3 FY2024, three months to 2024-09-30$6.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure5.6Interest expense, Q4 FY2024, three months to 2024-12-31$5.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure3.0Interest expense, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure3.0Interest expense, Q2 FY2025, three months to 2025-06-30$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure3.1Interest expense, Q3 FY2025, three months to 2025-09-30$3.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure3.0Interest expense, Q4 FY2025, three months to 2025-12-31$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure4.4Interest expense, Q1 FY2026, three months to 2026-03-31$4.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure3.4Interest expense, Q2 FY2026, three months to 2026-06-30$3.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Income tax$m3.0Income tax, Q3 FY2023, three months to 2023-09-30$3.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$25.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.3Income tax, Q1 FY2024, three months to 2024-03-31$324.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure0.3Income tax, Q4 FY2024, three months to 2024-12-31$323.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.3Income tax, Q1 FY2025, three months to 2025-03-31$279.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure0.3Income tax, Q2 FY2025, three months to 2025-06-30$342.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure0.1Income tax, Q3 FY2025, three months to 2025-09-30$80.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure0.5Income tax, Q4 FY2025, three months to 2025-12-31$470.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$93.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$136.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Net income$m(44.8)Net income, Q3 FY2023, three months to 2023-09-30−$44.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure(66.3)Net income, Q4 FY2023, three months to 2023-12-31−$66.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(35.4)Net income, Q1 FY2024, three months to 2024-03-31−$35.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure(52.3)Net income, Q2 FY2024, three months to 2024-06-30−$52.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure(41.5)Net income, Q3 FY2024, three months to 2024-09-30−$41.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure(10.8)Net income, Q4 FY2024, three months to 2024-12-31−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(25.1)Net income, Q1 FY2025, three months to 2025-03-31−$25.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure(15.9)Net income, Q2 FY2025, three months to 2025-06-30−$15.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure7.4Net income, Q3 FY2025, three months to 2025-09-30$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure17.4Net income, Q4 FY2025, three months to 2025-12-31$17.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(11.3)Net income, Q1 FY2026, three months to 2026-03-31−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure15.0Net income, Q2 FY2026, three months to 2026-06-30$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Diluted EPS$ per share(0.73)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figurenot reported(0.32)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure(0.42)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure(0.33)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure(0.13)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure0.06Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figurenot reported(0.09)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure0.11Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Basic EPS$ per share(0.73)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figurenot reported(0.32)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure(0.42)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure(0.33)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figurenot reported(0.20)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure(0.13)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure0.06Basic EPS, Q3 FY2025, three months to 2025-09-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figurenot reported(0.09)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure0.11Basic EPS, Q2 FY2026, three months to 2026-06-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure

Balance sheet

Cash and equivalents$34.1m, Q2 FY2026
Long-term debt$102.0m, Q2 FY2026
Shareholders' equity$220.6m, Q2 FY2026
Arcutis Biotherapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m107Cash and equivalents, Q3 FY2023, at 2023-09-30$107.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-03, accession 0001787306-23-000124.Report this figure88.4Cash and equivalents, FY2023, at 2023-12-31$88.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-25, accession 0001787306-25-000029.Report this figure190Cash and equivalents, Q1 FY2024, at 2024-03-31$190.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001787306-24-000079.Report this figure84.3Cash and equivalents, Q2 FY2024, at 2024-06-30$84.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001787306-24-000124.Report this figure135Cash and equivalents, Q3 FY2024, at 2024-09-30$134.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure71.3Cash and equivalents, FY2024, at 2024-12-31$71.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001787306-26-000018.Report this figure53.1Cash and equivalents, Q1 FY2025, at 2025-03-31$53.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure72.7Cash and equivalents, Q2 FY2025, at 2025-06-30$72.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure47.1Cash and equivalents, Q3 FY2025, at 2025-09-30$47.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure42.9Cash and equivalents, FY2025, at 2025-12-31$42.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure34.8Cash and equivalents, Q1 FY2026, at 2026-03-31$34.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure34.1Cash and equivalents, Q2 FY2026, at 2026-06-30$34.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Current assets$m282Current assets, Q3 FY2023, at 2023-09-30$281.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0001787306-23-000124.Report this figure330Current assets, FY2023, at 2023-12-31$330.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0001787306-25-000029.Report this figure468Current assets, Q1 FY2024, at 2024-03-31$468.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001787306-24-000079.Report this figure435Current assets, Q2 FY2024, at 2024-06-30$434.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001787306-24-000124.Report this figure424Current assets, Q3 FY2024, at 2024-09-30$423.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure336Current assets, FY2024, at 2024-12-31$335.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001787306-26-000018.Report this figure324Current assets, Q1 FY2025, at 2025-03-31$323.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure333Current assets, Q2 FY2025, at 2025-06-30$332.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure349Current assets, Q3 FY2025, at 2025-09-30$349.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure411Current assets, FY2025, at 2025-12-31$411.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure438Current assets, Q1 FY2026, at 2026-03-31$438.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure468Current assets, Q2 FY2026, at 2026-06-30$467.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Total assets$m293Total assets, Q3 FY2023, at 2023-09-30$293.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0001787306-23-000124.Report this figure341Total assets, FY2023, at 2023-12-31$341.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0001787306-25-000029.Report this figure479Total assets, Q1 FY2024, at 2024-03-31$478.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001787306-24-000079.Report this figure445Total assets, Q2 FY2024, at 2024-06-30$444.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001787306-24-000124.Report this figure437Total assets, Q3 FY2024, at 2024-09-30$437.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure349Total assets, FY2024, at 2024-12-31$348.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001787306-26-000018.Report this figure344Total assets, Q1 FY2025, at 2025-03-31$344.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure352Total assets, Q2 FY2025, at 2025-06-30$352.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure371Total assets, Q3 FY2025, at 2025-09-30$371.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure433Total assets, FY2025, at 2025-12-31$433.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure460Total assets, Q1 FY2026, at 2026-03-31$460.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure489Total assets, Q2 FY2026, at 2026-06-30$488.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Current liabilities$m41.9Current liabilities, Q3 FY2023, at 2023-09-30$41.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0001787306-23-000124.Report this figure46.7Current liabilities, FY2023, at 2023-12-31$46.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0001787306-25-000029.Report this figure47.3Current liabilities, Q1 FY2024, at 2024-03-31$47.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001787306-24-000079.Report this figure51.4Current liabilities, Q2 FY2024, at 2024-06-30$51.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001787306-24-000124.Report this figure172Current liabilities, Q3 FY2024, at 2024-09-30$172.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure81.0Current liabilities, FY2024, at 2024-12-31$81.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001787306-26-000018.Report this figure91.1Current liabilities, Q1 FY2025, at 2025-03-31$91.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure104Current liabilities, Q2 FY2025, at 2025-06-30$103.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure99.8Current liabilities, Q3 FY2025, at 2025-09-30$99.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure130Current liabilities, FY2025, at 2025-12-31$129.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure163Current liabilities, Q1 FY2026, at 2026-03-31$163.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure160Current liabilities, Q2 FY2026, at 2026-06-30$160.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Total liabilities$m246Total liabilities, Q3 FY2023, at 2023-09-30$246.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0001787306-23-000124.Report this figure253Total liabilities, FY2023, at 2023-12-31$252.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0001787306-25-000029.Report this figure254Total liabilities, Q1 FY2024, at 2024-03-31$253.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001787306-24-000079.Report this figure258Total liabilities, Q2 FY2024, at 2024-06-30$258.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001787306-24-000124.Report this figure281Total liabilities, Q3 FY2024, at 2024-09-30$280.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure191Total liabilities, FY2024, at 2024-12-31$191.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001787306-26-000018.Report this figure201Total liabilities, Q1 FY2025, at 2025-03-31$201.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure213Total liabilities, Q2 FY2025, at 2025-06-30$213.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure213Total liabilities, Q3 FY2025, at 2025-09-30$212.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure243Total liabilities, FY2025, at 2025-12-31$243.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure270Total liabilities, Q1 FY2026, at 2026-03-31$270.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure268Total liabilities, Q2 FY2026, at 2026-06-30$268.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Long-term debt$m201Long-term debt, Q3 FY2023, at 2023-09-30$200.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-03, accession 0001787306-23-000124.Report this figure202Long-term debt, FY2023, at 2023-12-31$201.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-25, accession 0001787306-25-000029.Report this figure203Long-term debt, Q1 FY2024, at 2024-03-31$202.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-14, accession 0001787306-24-000079.Report this figure204Long-term debt, Q2 FY2024, at 2024-06-30$203.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-14, accession 0001787306-24-000124.Report this figure105Long-term debt, Q3 FY2024, at 2024-09-30$105.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure107Long-term debt, FY2024, at 2024-12-31$107.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-25, accession 0001787306-26-000018.Report this figure108Long-term debt, Q1 FY2025, at 2025-03-31$107.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure107Long-term debt, Q2 FY2025, at 2025-06-30$107.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure107Long-term debt, Q3 FY2025, at 2025-09-30$107.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure108Long-term debt, FY2025, at 2025-12-31$108.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure101Long-term debt, Q1 FY2026, at 2026-03-31$101.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure102Long-term debt, Q2 FY2026, at 2026-06-30$102.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Current portion of debt$mnot reported0.0Current portion of debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figurenot reportednot reported99.5Current portion of debt, Q3 FY2024, at 2024-09-30$99.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-25, accession 0001787306-26-000018.Report this figurenot reported1.0Current portion of debt, Q2 FY2025, at 2025-06-30$1.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure1.0Current portion of debt, Q3 FY2025, at 2025-09-30$1.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure1.0Current portion of debt, FY2025, at 2025-12-31$1.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure8.0Current portion of debt, Q1 FY2026, at 2026-03-31$8.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure7.0Current portion of debt, Q2 FY2026, at 2026-06-30$7.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure
Shareholders' equity$m46.7Shareholders' equity, Q3 FY2023, at 2023-09-30$46.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure88.7Shareholders' equity, FY2023, at 2023-12-31$88.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001787306-26-000018.Report this figure225Shareholders' equity, Q1 FY2024, at 2024-03-31$224.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure186Shareholders' equity, Q2 FY2024, at 2024-06-30$186.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure157Shareholders' equity, Q3 FY2024, at 2024-09-30$156.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure158Shareholders' equity, FY2024, at 2024-12-31$157.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure143Shareholders' equity, Q1 FY2025, at 2025-03-31$142.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure139Shareholders' equity, Q2 FY2025, at 2025-06-30$139.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure158Shareholders' equity, Q3 FY2025, at 2025-09-30$158.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure189Shareholders' equity, FY2025, at 2025-12-31$189.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure190Shareholders' equity, Q1 FY2026, at 2026-03-31$189.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure221Shareholders' equity, Q2 FY2026, at 2026-06-30$220.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure

Cash flow

Operating cash flow$12.6m, Q2 FY2026
Capital expenditure$158.0k, Q2 FY2026
Arcutis Biotherapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(44.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$44.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001787306-24-000153. Derived: 9-month figure less the 6-month figure.Report this figure(56.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$56.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(31.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$31.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure(45.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$45.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001787306-25-000124. Derived: 6-month figure less the 3-month figure.Report this figure(34.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$34.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001787306-25-000144. Derived: 9-month figure less the 6-month figure.Report this figure(0.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$748.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure(30.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$30.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure0.3Operating cash flow, Q2 FY2025, three months to 2025-06-30$324.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001787306-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure(1.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001787306-25-000144. Derived: 9-month figure less the 6-month figure.Report this figure26.2Operating cash flow, Q4 FY2025, three months to 2025-12-31$26.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure2.2Operating cash flow, Q1 FY2026, three months to 2026-03-31$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure12.6Operating cash flow, Q2 FY2026, three months to 2026-06-30$12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001787306-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$64.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001787306-24-000153. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001787306-25-000124. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$143.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001787306-25-000144. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$608.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$78.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001787306-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001787306-25-000144. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001787306-26-000018. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$158.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001787306-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)135.90m, Q2 FY2026
Arcutis Biotherapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares57.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3057,091,743 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0001787306-23-000124.Report this figure61.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3161,169,089 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001787306-24-000079.Report this figure61.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3061,430,620 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001787306-24-000124.Report this figure61.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3061,727,278 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001787306-24-000153.Report this figure111Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31111,048,525 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001787306-25-000092.Report this figure123Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30123,481,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001787306-25-000124.Report this figure124Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30124,302,317 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure0.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31126,037 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure127Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30126,997,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure133Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30132,884,567 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001787306-25-000144.Report this figure0.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31129,365 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001787306-26-000040.Report this figure136Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30135,898,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure

Shares outstanding: 125.69mShares outstanding, period not labelled, at 2026-07-31125,691,961 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001787306-26-000051.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.